NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/11/2025
Voltar para busca
Dado oficial do USPTO
DENK INGREDIENTS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DENK INGREDIENTS
ST13
US500000079271037Classe
1, 3, 5, 35
Pedido
79271037
Registro
6177146
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
19/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 3, 5, 35
Data de depósito
16/05/2019
Data de registro
20/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/10/2020
Última transação
19/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
SABLE, ERIC
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DENK PHARMA GmbH & Co. KG
Denk Ingredients GmbH
Representantes
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industryscienceagriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticidesin particular for use in the fooddietary supplementpharmaceutical and cosmetics industriesincluding in the form of precursors and intermediatesbeing additives and auxiliaries; artificial sweeteners
Classe 3
Plant extracts and vegetable oils for cosmetic purposesincluding in the form of precursors and intermediatesbeing additives and auxiliariesplant extracts and vegetable oils sold as components of cosmetics
Classe 5
chemicals for pharmaceutical and medical purposes sold as the components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolismblood and blood forming organscardiovascular systemgenito-urinary system and sex hormonesantiinfectives for systemic usemusculo-skeletal systemnervous system and respiratory systemdisturbances with and support of digestive enzymesfor optimizing the supply of nutrients to mother and childfor the promotion of fertilityfor the relief and elimination of lactose intolerancefor the development of teethbones and muscles growthfor care during pregnancy and breastfeedingfor supporting the memoryconcentration and learningfor the care of the immune systemfor the strengthening and maintenance of jointscartilagebones and musclesfor the magnesium supply of heartnerves and musclesfor increasing the iron requirementfor increasing the sperm formation and for the folic acid care before and during pregnancy; animal and vegetable oils and plant extracts for pharmaceutical and medical purposes sold as components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolismblood and blood forming organscardiovascular systemgenito-urinary system and sex hormonesantiinfectives for systemic usemusculo-skeletal systemnervous system and respiratory systemdisturbances with and support of digestive enzymesfor optimizing the supply of nutrients to mother and childfor the promotion of fertilityfor the relief and elimination of lactose intolerancefor the development of teethbones and muscles growthfor care during pregnancy and breastfeedingfor supporting the memoryconcentration and learningfor the care of the immune systemfor the strengthening and maintenance of jointscartilagebones and musclesfor the magnesium supply of heartnerves and musclesfor increasing the iron requirementfor increasing the sperm formation and for the folic acid care before and during pregnancy; protein supplements for pharmaceutical and medical purposes; nutritional supplements for pharmaceutical and medical purposes; all the aforesaid goods being in the form of precursors and intermediatesbeing additives and auxiliaries
Classe 35
Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industryscienceagriculturehorticulture and forestryespecially for use in the foodstufffood supplementpharmaceutical and cosmetics industriesartificial sweetenerspains and dietsplant extracts and plant oils for cosmetic purposeschemical preparations for pharmaceutical and medical purposesanimal oils and plant oils as well as plant extracts for pharmaceutical and medical purposesproteins for pharmaceutical and medical purposesfood supplements for pharmaceutical and medical purposesminerals and vitamins
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
20/10/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/02/2021
FIMP
FINAL DISPOSITION PROCESSED
06/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
20/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2020
PUBO
PUBLISHED FOR OPPOSITION
04/08/2020
GPNX
NOTIFICATION PROCESSED BY IB
31/07/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/07/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/07/2020
ALIE
ASSIGNED TO LIE
30/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/06/2020
DCPN
CHANGE OF OWNER RECEIVED FROM IB
25/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/06/2020
ATRV
ATTORNEY REVIEW COMPLETED
13/01/2020
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
10/01/2020
RFNT
REFUSAL PROCESSED BY IB
04/01/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
27/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/12/2019
RFRR
REFUSAL PROCESSED BY MPU
13/12/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/11/2019
CNRT
NON-FINAL ACTION WRITTEN
19/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
16/11/2019
DOCK
ASSIGNED TO EXAMINER
12/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/11/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DENK INGREDIENTS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.